Armistice Capital, LLC Organon & Co. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $17.1 Million - $25.7 Million	800,000 Added 33.33%	3,200,000 $75.3 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $16.5 Million - $20.3 Million	708,000 Added 41.84%	2,400,000 $67.1 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $39.6 Million - $58 Million	1,692,000 New	1,692,000 $39.6 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.